| Eartheart Llc | |
|
4307 S Leonard Springs Rd Bloomington IN 47403-4078 | |
| (812) 345-2176 | |
| (206) 984-2440 |
| Full Name | Eartheart Llc |
|---|---|
| Speciality | Counselor |
| Location | 4307 S Leonard Springs Rd, Bloomington, Indiana |
| Authorized Official Name and Position | Bret Eartheart (TIN OWNER) |
| Authorized Official Contact | 8123452176 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Eartheart Llc 4307 S Leonard Springs Rd Bloomington IN 47403-4078 Ph: (812) 345-2176 | Eartheart Llc 4307 S Leonard Springs Rd Bloomington IN 47403-4078 Ph: (812) 345-2176 |
| NPI Number | 1720444813 |
|---|---|
| Provider Enumeration Date | 01/06/2016 |
| Last Update Date | 11/29/2018 |
| Medicare PECOS PAC ID | 5597061390 |
|---|---|
| Medicare Enrollment ID | O20160303002178 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
Heart specialists at Johns Hopkins Heart Institute have been awarded more than $12 million from the National Heart, Lung, and Blood Institute (NHLBI) to study how stem cell therapies can be used to treat hearts damaged by heart attack or heart failure.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
NewGen Therapeutics, Inc. today announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults.
› Verified 1 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1720444813 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YM0800X | Counselor - Mental Health | (* (Not Available)) | Primary |
| Provider Name | Caitlin E Bryte |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1972882835 PECOS PAC ID: 8022271634 Enrollment ID: I20120518000004 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
Heart specialists at Johns Hopkins Heart Institute have been awarded more than $12 million from the National Heart, Lung, and Blood Institute (NHLBI) to study how stem cell therapies can be used to treat hearts damaged by heart attack or heart failure.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
NewGen Therapeutics, Inc. today announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults.
› Verified 1 days ago
| Provider Name | Bret D Eartheart |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1760788913 PECOS PAC ID: 3375761828 Enrollment ID: I20140826001467 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
Heart specialists at Johns Hopkins Heart Institute have been awarded more than $12 million from the National Heart, Lung, and Blood Institute (NHLBI) to study how stem cell therapies can be used to treat hearts damaged by heart attack or heart failure.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
NewGen Therapeutics, Inc. today announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults.
› Verified 1 days ago
| Provider Name | Audra Nicole Miller |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770165763 PECOS PAC ID: 9335558220 Enrollment ID: I20210505001456 |
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
Heart specialists at Johns Hopkins Heart Institute have been awarded more than $12 million from the National Heart, Lung, and Blood Institute (NHLBI) to study how stem cell therapies can be used to treat hearts damaged by heart attack or heart failure.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
NewGen Therapeutics, Inc. today announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults.
› Verified 1 days ago
News Archive
Curis, Inc., a drug development company seeking to develop next generation targeted small molecule drug candidates for cancer treatment, today reported its financial results for the second quarter ended June 30, 2011.
Heart specialists at Johns Hopkins Heart Institute have been awarded more than $12 million from the National Heart, Lung, and Blood Institute (NHLBI) to study how stem cell therapies can be used to treat hearts damaged by heart attack or heart failure.
Researchers in the UK have reported the protocol for a longitudinal study investigating the risk of adverse physical and mental health outcomes related to coronavirus disease 2019 (COVID-19) among healthcare workers from different ethnic groups.
NewGen Therapeutics, Inc. today announced the publication of preclinical research strongly supporting NT-113, the company's novel irreversible pan-erbB inhibitor (EGFR, HER2 and HER4), as a potential new treatment for glioblastoma multiforme (GBM), the most common and most aggressive malignant primary brain tumor in adults.
› Verified 1 days ago
Dr. Katy Kopp Miller, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 120 W 7th St Ste 108, Bloomington, IN 47404 Phone: 765-425-3412 | |
Diane Menke Pence, Lmhc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 205 N College Ave, Ste 613, Bloomington, IN 47404 Phone: 812-333-3440 Fax: 812-333-3444 | |
Huts Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2801 E Plateau Place, Bloomington, IN 47401 Phone: 804-386-9216 Fax: 804-464-1483 | |
Bloomington Meadows Physicians Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 3600 N Prow Rd, Bloomington, IN 47404 Phone: 812-331-8000 Fax: 812-331-8985 | |
Angela R Marshall Psyd Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2525 W Vernal Pike, Bloomington, IN 47404 Phone: 812-345-5114 Fax: 812-339-0369 | |
New Outlook Counseling Center Inc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 5010 N Stone Mill Rd, Suite B, Bloomington, IN 47408 Phone: 812-929-2193 Fax: 888-789-8394 | |
Leah Sinn Iversen Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 518 N Colony Ct, Bloomington, IN 47408 Phone: 812-320-2017 |